Conference Call on Q3/2021 financial results
Hannover, 4 November 2021
Agenda
2 | Property & Casualty reinsurance | 6 |
3 | Life & Health reinsurance | 11 |
4 | Investments | 14 |
5 | Target Matrix | 17 |
6 | Outlook | 19 |
Appendix | 22 | |
2 Conference Call on Q3/2021 financial results
| 1 Group overview | 2 | 3 | 4 | 5 | 6 |
Strong nine-month results demonstrate resilience and earnings power in a heavily loss-affected year
GWP | F/x-adj. +14.4% | |
24.000 | 19,295 | 21,620 |
12.000 | ||
+12.0% | ||
0 | ||
Q1-3/2020 | Q1-3/2021 |
NPE | F/x-adj. +13.9% |
24.000 | 17,634 |
15,772 | |
12.000 | |
+11.8% | |
0 | |
Q1-3/2020 | Q1-3/2021 |
EBIT | |
1400 | 1,281 |
903 | |
700 | |
+41.8% | |
0 | |
Q1-3/2020 | Q1-3/2021 |
Group net income
1400 | |
668 | 856 |
700 | |
+28.2% | |
0 | |
Q1-3/2020 | Q1-3/2021 |
10.2% | EUR 94.60 | 239% | ||
Return on Equity | Book value per share | Solvency II ratio | ||
above target of 8.9% | +3.8%; favourable earnings and slight increase in net OCI | 30.09.2021 | ||
offset by dividend payments | ||||
P&C R/I | C/R: 97.9% |
- Strong and diversified premium growth (f/x-adj. +17.7%)
- Combined ratio of 97.9% above target due to large losses of EUR 1,070 m. exceeding the budget for Q1-3/2021 by EUR 221 m. (1.8% of NPE)
- Covid-19net loss estimate unchanged at EUR 950 m.
L&H R/I | EBIT: 220 m. |
- Favourable premium growth (f/x-adj. +6.9%)
- EBIT impacted by Covid-19 mortality claims of EUR 404 m., partly offset by positive one-off effects from restructuring within US mortality portfolio in Q1/2021 (EUR 129 m.) and from Longevity (EUR 99 m.)
Investments | RoI: 2.9% |
- AuM increased by 12.3% to EUR 55 bn. mainly driven by very strong operating cash flow
- RoI from AuM: 2.9%, above full-year target of 2.4%
- Increase in ordinary investment income mainly due to higher contribution from alternative investments and volume growth
Figures in EUR millions, unless otherwise stated
3 Conference Call on Q3/2021 financial results
| 1 Group overview | 2 | 3 | 4 | 5 | 6 |
Very strong operating cash flow driven by profitable premium growth
AuM +12.3%, cash flow and f/x effects more than offset lower asset valuation
Operating cash flow | in m. EUR |
4,193
3,231 | 1,513 | |||
641 | ||||
2,509 | ||||
2,225 | 39 | |||
941 | 919 | 994 | ||
515 | ||||
1,694 | ||||
225 | ||||
561 | 692 | 736 | ||
821 | ||||
519 | 390 | 1,686 | ||
935 | ||||
627 | 709 | |||
389 | ||||
2017 | 2018 | 2019 | 2020 | 2021 |
Q1 Q2 Q3 Q4
Assets under own management (AuM) | in m. EUR | ||||
55,030 | |||||
47,629 | 49,002 | ||||
42,197 | |||||
40,057 | |||||
2017 | 2018 | 2019 | 2020 | 30.09.2021 |
4 Conference Call on Q3/2021 financial results
| 1 Group overview | 2 | 3 | 4 | 5 | 6 |
Shareholders' equity up by 3.8% | ||||||||||
Policyholders' surplus | in m. EUR Change in shareholders' equity | in m. EUR | ||||||||
14,071 | 15,238 | 856 | 11,409 | |||||||
509 | ||||||||||
13,589 | 10,995 | |||||||||
2,978 | ||||||||||
2,232 | (543) | |||||||||
(408) | ||||||||||
2,234 | ||||||||||
10,779 | 11,035 | 844 | 852 | |||||||
826 | ||||||||||
1,492 | 1,493 | |||||||||
758 | 765 | |||||||||
10,528 | 10,995 | 11,409 | ||||||||
8,528 | 8,777 | |||||||||
2017 | 2018 | 2019 | 2020 | 30.09.2021 | Shareholders' | Net | Dividend | Change in | Currency | Shareholders' |
Shareholders' equity | Non-controlling interests | Hybrid | equity | income | payment | unrealised | translation | equity | ||
31.12.2020 | gains/losses | and other | 30.09.2021 |
5 Conference Call on Q3/2021 financial results
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Hannover Rück SE published this content on 04 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2021 06:41:03 UTC.